Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance, presenting a buying opportunity around $163/share. Zoetis' unique advantages and pricing ...
StockStory.org on MSN
Zoetis (NYSE:ZTS) Posts Q4 Sales In Line With Estimates But Stock Drops
Animal health company Zoetis (NYSE:ZTS) in Q4 CY2024, with sales up 4.7% year on year to $2.32 billion. On the other hand, the company’s full-year revenue guidance of $9.3 billion at the midpoint came ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results